International Congress on Organoid Research and Drug Screening
ICORDS
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This session will explore the latest innovations in organoid technology, including novel methods for organoid generation and manipulation. Participants will discuss the implications of these advancements for regenerative medicine and disease modeling.
SDG 3
SDG 4
This track focuses on the application of organoids in drug screening processes, highlighting their potential to enhance predictive accuracy in preclinical studies. Researchers will present case studies demonstrating the efficacy of organoid models in identifying therapeutic candidates.
SDG 3
SDG 9
This session aims to bridge the gap between laboratory research and clinical applications of organoids. Discussions will center on successful translational strategies and the challenges faced in implementing organoid technology in clinical settings.
SDG 3
SDG 9
Participants will delve into the use of organoids as models for understanding complex disease mechanisms, including cancer and genetic disorders. This track will highlight how organoid systems can replicate disease phenotypes and facilitate personalized medicine approaches.
SDG 3
SDG 4
This session will examine the role of organoids in regenerative medicine, particularly in the context of tissue engineering. Experts will discuss the potential of organoid-derived tissues for transplantation and repair of damaged organs.
SDG 3
SDG 9
This track will focus on the integration of organoid technology into precision medicine initiatives. Presentations will cover how patient-derived organoids can inform tailored treatment strategies and improve therapeutic outcomes.
SDG 3
SDG 9
This session will address the ethical implications surrounding organoid research, including issues related to consent, ownership, and the potential for organoid-derived therapies. Experts will engage in discussions on establishing ethical guidelines for future research.
SDG 16
This track will showcase cutting-edge techniques in the culturing and maintenance of organoids, emphasizing advancements in 3D culture systems and bioreactors. Attendees will learn about optimizing conditions for organoid growth and functionality.
SDG 9
This session will highlight clinical studies that have successfully employed organoid models to inform treatment decisions and patient management. Researchers will share insights into the clinical relevance and outcomes of these studies.
SDG 3
SDG 9
This track will focus on the application of organoids in the study of infectious diseases, including viral and bacterial infections. Presentations will explore how organoid models can enhance our understanding of pathogen-host interactions.
SDG 3
SDG 9
This session will speculate on the future landscape of organoid research, considering emerging technologies and potential applications. Experts will discuss the next steps for integrating organoids into mainstream biomedical research and clinical practice.
SDG 9
SDG 11